RT Book, Section
A1 Goldshtein, Daniel
A1 Chan, Sze Wah Samuel
SR Print(0)
ID 1208961840
T1 Tisotumab Vedotin as Second or Third-Line Therapy for Recurrent Cervical Cancer
T2 2 Minute Medicine
YR 2015
FD 2015
PB McGraw Hill
PP New York, NY
SN 
LK accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=649206
RD 2024/10/04
AB